Señales en vivo de NVCT | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (7 may 2024 @ 16:00):

Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology...

Stats
Volumen de hoy	161 467
Volumen promedio	100 811
Capitalización de mercado	132.09M
EPS	$0 ( 2024-03-05 )
Próxima fecha de ganancias	( $-0.400 ) 2024-08-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-5.03
ATR14	$0.0730 (1.02%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-18	Bentsur Ron	Buy	5 000	Common Stock
2024-01-03	Poradosu Enrique	Buy	130 000	Common Stock
2024-01-03	Shemesh Shay	Buy	130 000	Common Stock
2023-10-10	Bentsur Ron	Buy	640	Common Stock
2023-10-09	Bentsur Ron	Buy	830	Common Stock

INSIDER POWER
100.00
Last 100 transactions
Buy: 1 056 063 \| Sell: 0

Volumen Correlación

Largo: -0.18 (neutral)

Corto: 0.63 (weak)

Signal:(54.785) Neutral

Nuvectis Pharma, Inc. Correlación

10 Correlaciones Más Positivas
TERN	0.813
VIR	0.805
LI	0.802

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Nuvectis Pharma, Inc. Correlación - Moneda/Commodity

0.06
( neutral )

0.20
( neutral )

0.24
( neutral )

0.25
( neutral )

-0.58
( weak negative )

-0.28
( neutral )

Nuvectis Pharma, Inc. Finanzas

Annual	2023
Ingresos:	$0
Beneficio Bruto:	$-22.90M (0.00 %)
EPS:	$-1.430

FY	2023
Ingresos:	$0
Beneficio Bruto:	$-22.90M (0.00 %)
EPS:	$-1.430

FY	2022
Ingresos:	$149 000
Beneficio Bruto:	$-19.09M (-12 808.72 %)
EPS:	$-1.480

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-1.091

Financial Reports:

No articles found.

Nuvectis Pharma, Inc.

Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src and YES1 kinases. The company was incorporated in 2020 and is based in Fort Lee, New Jersey.

Actualizaciones en tiempo real para Nuvectis Pharma, Inc. [NVCT]

Upcoming Earnings Alert